866-997-4948(US-Canada Toll Free)

Global Orphan Drugs Market Professional Survey Report 2017

Published By :

QYResearch

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 119 Pages

This report studies Orphan Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Bayer
Bristol-Myers Squibb
Novartis
Pfizer
Roche
Sanofi
Johnson & Johnson
Eli Lilly & Co.
Celgene
Biogen IDEC
Pharmacyclics
Vertex
Onyx
AstraZeneca
Baxter

By types, the market can be split into
New Molecular Entities Drugs
Biologics Drugs
Other

By Application, the market can be split into
Oncologic
Metabolic
Hematologic-Immunologic
Infections/Parasitic
Other

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India


Table of Contents

Global Orphan Drugs Market Professional Survey Report 2017
1 Industry Overview of Orphan Drugs
1.1 Definition and Specifications of Orphan Drugs
1.1.1 Definition of Orphan Drugs
1.1.2 Specifications of Orphan Drugs
1.2 Classification of Orphan Drugs
1.2.1 New Molecular Entities Drugs
1.2.2 Biologics Drugs
1.2.3 Other
1.3 Applications of Orphan Drugs
1.3.1 Oncologic
1.3.2 Metabolic
1.3.3 Hematologic-Immunologic
1.3.4 Infections/Parasitic
1.3.5 Other
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Orphan Drugs
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Orphan Drugs
2.3 Manufacturing Process Analysis of Orphan Drugs
2.4 Industry Chain Structure of Orphan Drugs

3 Technical Data and Manufacturing Plants Analysis of Orphan Drugs
3.1 Capacity and Commercial Production Date of Global Orphan Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Orphan Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Orphan Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Orphan Drugs Major Manufacturers in 2016

4 Global Orphan Drugs Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Orphan Drugs Capacity and Growth Rate Analysis
4.2.2 2016 Orphan Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Orphan Drugs Sales and Growth Rate Analysis
4.3.2 2016 Orphan Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Orphan Drugs Sales Price
4.4.2 2016 Orphan Drugs Sales Price Analysis (Company Segment)

5 Orphan Drugs Regional Market Analysis
5.1 North America Orphan Drugs Market Analysis
5.1.1 North America Orphan Drugs Market Overview
5.1.2 North America 2012-2017E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Orphan Drugs Sales Price Analysis
5.1.4 North America 2016 Orphan Drugs Market Share Analysis
5.2 China Orphan Drugs Market Analysis
5.2.1 China Orphan Drugs Market Overview
5.2.2 China 2012-2017E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Orphan Drugs Sales Price Analysis
5.2.4 China 2016 Orphan Drugs Market Share Analysis
5.3 Europe Orphan Drugs Market Analysis
5.3.1 Europe Orphan Drugs Market Overview
5.3.2 Europe 2012-2017E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Orphan Drugs Sales Price Analysis
5.3.4 Europe 2016 Orphan Drugs Market Share Analysis
5.4 Southeast Asia Orphan Drugs Market Analysis
5.4.1 Southeast Asia Orphan Drugs Market Overview
5.4.2 Southeast Asia 2012-2017E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Orphan Drugs Sales Price Analysis
5.4.4 Southeast Asia 2016 Orphan Drugs Market Share Analysis
5.5 Japan Orphan Drugs Market Analysis
5.5.1 Japan Orphan Drugs Market Overview
5.5.2 Japan 2012-2017E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Orphan Drugs Sales Price Analysis
5.5.4 Japan 2016 Orphan Drugs Market Share Analysis
5.6 India Orphan Drugs Market Analysis
5.6.1 India Orphan Drugs Market Overview
5.6.2 India 2012-2017E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Orphan Drugs Sales Price Analysis
5.6.4 India 2016 Orphan Drugs Market Share Analysis

6 Global 2012-2017E Orphan Drugs Segment Market Analysis (by Type)
6.1 Global 2012-2017E Orphan Drugs Sales by Type
6.2 Different Types of Orphan Drugs Product Interview Price Analysis
6.3 Different Types of Orphan Drugs Product Driving Factors Analysis
6.3.1 New Molecular Entities Drugs of Orphan Drugs Growth Driving Factor Analysis
6.3.2 Biologics Drugs of Orphan Drugs Growth Driving Factor Analysis
6.3.3 Other of Orphan Drugs Growth Driving Factor Analysis

7 Global 2012-2017E Orphan Drugs Segment Market Analysis (by Application)
7.1 Global 2012-2017E Orphan Drugs Consumption by Application
7.2 Different Application of Orphan Drugs Product Interview Price Analysis
7.3 Different Application of Orphan Drugs Product Driving Factors Analysis
7.3.1 Oncologic of Orphan Drugs Growth Driving Factor Analysis
7.3.2 Metabolic of Orphan Drugs Growth Driving Factor Analysis
7.3.3 Hematologic-Immunologic of Orphan Drugs Growth Driving Factor Analysis
7.3.4 Infections/Parasitic of Orphan Drugs Growth Driving Factor Analysis
7.3.5 Other of Orphan Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Orphan Drugs
8.1 Bayer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Bayer 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Bayer 2016 Orphan Drugs Business Region Distribution Analysis
8.2 Bristol-Myers Squibb
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Bristol-Myers Squibb 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Bristol-Myers Squibb 2016 Orphan Drugs Business Region Distribution Analysis
8.3 Novartis
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Novartis 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Novartis 2016 Orphan Drugs Business Region Distribution Analysis
8.4 Pfizer
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Pfizer 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Pfizer 2016 Orphan Drugs Business Region Distribution Analysis
8.5 Roche
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Roche 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Roche 2016 Orphan Drugs Business Region Distribution Analysis
8.6 Sanofi
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Sanofi 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Sanofi 2016 Orphan Drugs Business Region Distribution Analysis
8.7 Johnson & Johnson
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Johnson & Johnson 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Johnson & Johnson 2016 Orphan Drugs Business Region Distribution Analysis
8.8 Eli Lilly & Co.
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Eli Lilly & Co. 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Eli Lilly & Co. 2016 Orphan Drugs Business Region Distribution Analysis
8.9 Celgene
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Celgene 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Celgene 2016 Orphan Drugs Business Region Distribution Analysis
8.10 Biogen IDEC
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Biogen IDEC 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Biogen IDEC 2016 Orphan Drugs Business Region Distribution Analysis
8.11 Pharmacyclics
8.12 Vertex
8.13 Onyx
8.14 AstraZeneca
8.15 Baxter

9 Development Trend of Analysis of Orphan Drugs Market
9.1 Global Orphan Drugs Market Trend Analysis
9.1.1 Global 2017-2022 Orphan Drugs Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Orphan Drugs Sales Price Forecast
9.2 Orphan Drugs Regional Market Trend
9.2.1 North America 2017-2022 Orphan Drugs Consumption Forecast
9.2.2 China 2017-2022 Orphan Drugs Consumption Forecast
9.2.3 Europe 2017-2022 Orphan Drugs Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Orphan Drugs Consumption Forecast
9.2.5 Japan 2017-2022 Orphan Drugs Consumption Forecast
9.2.6 India 2017-2022 Orphan Drugs Consumption Forecast
9.3 Orphan Drugs Market Trend (Product Type)
9.4 Orphan Drugs Market Trend (Application)

10 Orphan Drugs Marketing Type Analysis
10.1 Orphan Drugs Regional Marketing Type Analysis
10.2 Orphan Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Orphan Drugs by Region
10.4 Orphan Drugs Supply Chain Analysis

11 Consumers Analysis of Orphan Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis


12 Conclusion of the Global Orphan Drugs Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures
Figure Picture of Orphan Drugs
Table Product Specifications of Orphan Drugs
Table Classification of Orphan Drugs
Figure Global Production Market Share of Orphan Drugs by Type in 2016
Figure New Molecular Entities Drugs Picture
Table Major Manufacturers of New Molecular Entities Drugs
Figure Biologics Drugs Picture
Table Major Manufacturers of Biologics Drugs
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Orphan Drugs
Figure Global Consumption Volume Market Share of Orphan Drugs by Application in 2016
Figure Oncologic Examples
Table Major Consumers of Oncologic
Figure Metabolic Examples
Table Major Consumers of Metabolic
Figure Hematologic-Immunologic Examples
Table Major Consumers of Hematologic-Immunologic
Figure Infections/Parasitic Examples
Table Major Consumers of Infections/Parasitic
Figure Other Examples
Table Major Consumers of Other
Figure Market Share of Orphan Drugs by Regions
Figure North America Orphan Drugs Market Size (Million USD) (2012-2022)
Figure China Orphan Drugs Market Size (Million USD) (2012-2022)
Figure Europe Orphan Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Orphan Drugs Market Size (Million USD) (2012-2022)
Figure Japan Orphan Drugs Market Size (Million USD) (2012-2022)
Figure India Orphan Drugs Market Size (Million USD) (2012-2022)
Table Orphan Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Orphan Drugs in 2016
Figure Manufacturing Process Analysis of Orphan Drugs
Figure Industry Chain Structure of Orphan Drugs
Table Capacity and Commercial Production Date of Global Orphan Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Orphan Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Orphan Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Orphan Drugs Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Orphan Drugs 2012-2017
Figure Global 2012-2017E Orphan Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Orphan Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Orphan Drugs Capacity and Growth Rate
Table 2016 Global Orphan Drugs Capacity (K MT) List (Company Segment)
Table 2012-2017E Global Orphan Drugs Sales (K MT) and Growth Rate
Table 2016 Global Orphan Drugs Sales (K MT) List (Company Segment)
Table 2012-2017E Global Orphan Drugs Sales Price (USD/MT)
Table 2016 Global Orphan Drugs Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Orphan Drugs 2012-2017E
Figure North America 2012-2017E Orphan Drugs Sales Price (USD/MT)
Figure North America 2016 Orphan Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Orphan Drugs 2012-2017E
Figure China 2012-2017E Orphan Drugs Sales Price (USD/MT)
Figure China 2016 Orphan Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Orphan Drugs 2012-2017E
Figure Europe 2012-2017E Orphan Drugs Sales Price (USD/MT)
Figure Europe 2016 Orphan Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Orphan Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Orphan Drugs Sales Price (USD/MT)
Figure Southeast Asia 2016 Orphan Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Orphan Drugs 2012-2017E
Figure Japan 2012-2017E Orphan Drugs Sales Price (USD/MT)
Figure Japan 2016 Orphan Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Orphan Drugs 2012-2017E
Figure India 2012-2017E Orphan Drugs Sales Price (USD/MT)
Figure India 2016 Orphan Drugs Sales Market Share
Table Global 2012-2017E Orphan Drugs Sales (K MT) by Type
Table Different Types Orphan Drugs Product Interview Price
Table Global 2012-2017E Orphan Drugs Sales (K MT) by Application
Table Different Application Orphan Drugs Product Interview Price
Table Bayer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer Orphan Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Bayer Orphan Drugs Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bristol-Myers Squibb Orphan Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Bristol-Myers Squibb Orphan Drugs Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2015 Novartis Orphan Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Novartis Orphan Drugs Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Orphan Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Pfizer Orphan Drugs Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Orphan Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Roche Orphan Drugs Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Orphan Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Sanofi Orphan Drugs Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Orphan Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Johnson & Johnson Orphan Drugs Business Region Distribution
Table Eli Lilly & Co. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly & Co. Orphan Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Eli Lilly & Co. Orphan Drugs Business Region Distribution
Table Celgene Information List
Table Product A Overview
Table Product B Overview
Table 2016 Celgene Orphan Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Celgene Orphan Drugs Business Region Distribution
Table Biogen IDEC Information List
Table Product A Overview
Table Product B Overview
Table 2016 Biogen IDEC Orphan Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Biogen IDEC Orphan Drugs Business Region Distribution
Table Pharmacyclics Information List
Table Vertex Information List
Table Onyx Information List
Table AstraZeneca Information List
Table Baxter Information List
Figure Global 2017-2022 Orphan Drugs Market Size (K MT) and Growth Rate Forecast
Figure Global 2017-2022 Orphan Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Orphan Drugs Sales Price (USD/MT) Forecast
Figure North America 2017-2022 Orphan Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2017-2022 Orphan Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2017-2022 Orphan Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Orphan Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2017-2022 Orphan Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2017-2022 Orphan Drugs Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Orphan Drugs by Type 2017-2022
Table Global Consumption Volume (K MT) of Orphan Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Orphan Drugs by Region

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *